Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. It is administered by intravenous infusion. Eptinezumab was approved for medical use in the United States in February 2020.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Eptinezumab (en)
- Eptinézumab (fr)
|
rdfs:comment
| - Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. It is administered by intravenous infusion. Eptinezumab was approved for medical use in the United States in February 2020. (en)
- L'eptinézumab, commercialisé sous le nom de Vyepti par le groupe Lundbeck, est un anticorps monoclonal IgG1 humanisé, mais non glycosylée, qui se lie au peptide relié au gène de la calcitonine (CGRP) et empêche ainsi son activité biologique. (fr)
|
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
ATC suffix
| |
ATC prefix
| |
c
| |
CAS number
| |
ChemSpiderID
| |
class
| - Calcitonin gene-related peptide antagonist (en)
|
DrugBank
| |
H
| |
KEGG
| |
legal US
| |
n
| |
O
| |
routes of administration
| |
s
| |
source
| |
synonyms
| - ALD403, eptinezumab-jjmr (en)
|
target
| |
tradename
| |
type
| |
UNII
| |
has abstract
| - Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. It is administered by intravenous infusion. Eptinezumab was approved for medical use in the United States in February 2020. (en)
- L'eptinézumab, commercialisé sous le nom de Vyepti par le groupe Lundbeck, est un anticorps monoclonal IgG1 humanisé, mais non glycosylée, qui se lie au peptide relié au gène de la calcitonine (CGRP) et empêche ainsi son activité biologique. (fr)
|
DailyMedID
| |
legal AU
| |
legal CA
| |
legal EU
| |
mab type
| |
pregnancy AU
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
alternative name
| |
CAS number
| |
DrugBank
| |
FDA UNII code
| |
KEGG
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is foaf:primaryTopic
of | |